Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2025-12-26 @ 10:46 PM
NCT ID: NCT05538312
Description: None
Frequency Threshold: 5
Time Frame: From the first dose (Day 1) up to 35 days after the last dose of study intervention (up to 52 days).
Study: NCT05538312
Study Brief: A Study to Understand the Effect of Itraconazole on the Levels of a Study Medicine Called ARV-471 in Healthy Adults
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
ARV-471 200 mg Participants received a single dose of ARV-471 200 mg on Day 1 of Period 1. 0 None 0 12 2 12 View
Itraconazole 200 mg Participants received itraconazole 200 mg once daily alone over a period of Days 1-4 in Period 2. 0 None 0 12 3 12 View
ARV-471 200 mg + Itraconazole 200 mg Participants received a single dose of ARV-471 200 mg on Day 5 of Period 2 co-administered with itraconazole 200 mg once daily on Days 5-11 in Period 2. 0 None 0 12 2 12 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Abdominal pain NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA v26.0 View
Diarrhoea NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA v26.0 View
Gingival discomfort NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA v26.0 View
Fatigue NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA v26.0 View
Back pain NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA v26.0 View
Somnolence NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA v26.0 View
Nasal congestion NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA v26.0 View